Anti-Microbial Savior BioteQ , Ltd Profit Margin

Anti-Microbial Savior BioteQ , Ltd's profit margin stands at -9826.23% as of June 2026. That compares with -4283.76% in the prior-year period — down 129.4% year over year. That is below the Healthcare sector average of 10.58%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Anti-Microbial Savior BioteQ , Ltd reported -9826.23% in profit margin versus -4283.76% a year earlier — a 129.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Anti-Microbial Savior BioteQ , Ltd sits lower the Healthcare benchmark (10.58%) with a profit margin of -9826.23%. That is roughly 92971.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -9826.23% for Anti-Microbial Savior BioteQ , Ltd means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Anti-Microbial Savior BioteQ , Ltd's profit margin evolved across reporting periods, while the comparison chart places 6864.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.